Current Therapy Option for Necrotizing Enterocolitis: Practicalities and Challenge
Overview
Authors
Affiliations
Necrotizing enterocolitis (NEC) is one of the most prevalent neonatal gastrointestinal disorders. Despite ongoing breakthroughs in its treatment and prevention, the incidence and mortality associated with NEC remain high. New therapeutic approaches, such as breast milk composition administration, stem cell therapy, immunotherapy, and fecal microbiota transplantation (FMT) have recently evolved the prevention and the treatment of NEC. This study investigated the most recent advances in NEC therapeutic approaches and discussed their applicability to bring new insight to NEC treatment.
Provitera L, Tomaselli A, Algieri F, Tripodi M, Raffaeli G, Amodeo I Metabolites. 2024; 14(11).
PMID: 39590806 PMC: 11596930. DOI: 10.3390/metabo14110570.
Mackay C, Rath C, Rao S, Patole S Nutrients. 2024; 16(6).
PMID: 38542743 PMC: 10975714. DOI: 10.3390/nu16060832.
Wang S, Cai J, Shi A, Cao Y Zhongguo Dang Dai Er Ke Za Zhi. 2023; 25(8):855-863.
PMID: 37668035 PMC: 10484087. DOI: 10.7499/j.issn.1008-8830.2301082.
Progress in Research on Stem Cells in Neonatal Refractory Diseases.
Huang F, He Y, Zhang M, Luo K, Li J, Li J J Pers Med. 2023; 13(8).
PMID: 37623531 PMC: 10455340. DOI: 10.3390/jpm13081281.
Provitera L, Tomaselli A, Raffaeli G, Crippa S, Arribas C, Amodeo I Cells. 2023; 12(5).
PMID: 36899900 PMC: 10000931. DOI: 10.3390/cells12050760.